American Century Companies’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
ACA
BI
SL
American Century Companies's KYMR Position: Q2 2026 in Review
American Century Companies opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 8,196 shares worth $940K. The stake represents ﹤0.01% of the portfolio and ranks #2415 among its holdings. This is a return to the name: American Century Companies previously reported a position in KYMR as recently as Q4 2025.
American Century Companies first reported a position in KYMR in Q3 2020 and has held it in 19 quarters since. The position peaked at $11.9M in Q4 2021. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.
- American Century Companies held 8,196 shares of Kymera Therapeutics worth $940K as of Q2 2026.
- Kymera Therapeutics was a new American Century Companies position in Q2 2026.
- Kymera Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2415 holding.
- American Century Companies first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 19 quarters since.
- American Century Companies's Kymera Therapeutics position peaked at $11.9M in Q4 2021.
- 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.